Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 6, 2026

Back to the front page

Post Q3 EVC Update

EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.

EVC $832M
Nat Stewart - Stock Picking Newsletter 23 clicks

From X

@StableBread

Fajasy on X

The Tokyo Stock Exchange (TSE) delisted TOYO Co., Ltd’s $TOYO parent on September 26, partly over “deference” to the former chairman who still controls 59.8% of $TOYO. $TOYO’s governance traces back to Junsei Ryu, its Chairman and CEO until March 2026, who controlled 66.9% of $TOYO’s vote before the June offering, or 59.8% of today’s 42.7M shares by my count. He was also Representative Director, Chairman and CEO of Abalance until he gave up his representative role in March 2026. $TOYO’s 20-F calls Abalance its controlling shareholder and says Abalance’s board or president must approve $TOYO’s significant transactions, including investments above 5% of $TOYO’s total assets. As of June 30, that bar was $26.9M, which the $357M HJT cell plant $TOYO plans in Texas clears more than 13 times over. Abalance’s problems came to a head in 2026: → January 2026: The TSE fined Abalance ¥43.2M and, on January 31, designated its shares a “Security on Special Alert” over group governance and related-party controls. → July 31, 2026: The TSE moved Abalance to “Security Under Supervision.” → August 19, 2026: Abalance’s FY3/2026 results carried a going-concern warning, and its auditor disclaimed an opinion on its annual report. → September 26, 2026: The TSE delisted Abalance. The TSE’s stated reasons for the delisting say Abalance’s improvement plan didn’t address why its officers and employees stopped exercising independent judgment, which the exchange traced to “deference to the former Representative Director, Chairman and CEO and reluctance to challenge him.” That executive is Ryu, who held the title until March. The exchange also cited missing group-wide controls over deals where Abalance companies sold materials to outside processors and then bought the processed goods back. Put simply, some of Abalance’s overseas subsidiaries sold polysilicon to wafer makers and bought it back as wafers, and Abalance had to correct how it accounted for those deals in its FY3/2026 results. Abalance didn’t name those subsidiaries. $TOYO, for its part, buys polysilicon and gets its wafers from a “designated facility in Indonesia,” and neither company has said whether any of $TOYO’s transactions were among those corrected. So buying $TOYO means trusting Ryu, whose 59.8% stake outvotes all other holders combined, and a delisted parent with a going-concern warning to treat outside holders fairly.
@aleabitoreddit

Serenity on X

To my knowledge, $CRDO doesn't have in-house CW DFB laser manufacturing capabilities, so not quite... Dustphotonics integrates external CW lasers so Credo is another potential $MRVL for the need to M&A laser companies. They did another with Hyperlume earlier but that was for microLEDs, not CW. Lot of industry channel checks like Largan cast a lot of doubts over that microLED commercialization for CPO (not every short reach application).
@ParadisLabs

Paradis on X

$LITE shareholders should be annoyed... The 23.9% premium in the $MRVL deal is real on paper, but in dollars it's gone. 1. 4.5 $MRVL per $LITE = $1,132/share on 28 Oct = 23.9% above Lumentum's undisturbed $914. This is the 23.9% premium reported today. 2. Marvell has since fallen ~22% to $196.40 (Friday close). So 4.5 shares = ~$884 = 3.3% below Lumentum’s undisturbed price of $914. 3. The deal's $102.5B equity value is now ~$80B. 4. Lumentum fell ~8% in the same selloff to the ~$840s. 5. So even vs where Lumentum actually trades, the premium has shrunk from 23.9% to ~5%. I think Marvell needs to get back above ~$203 for Lumentum shareholders to see any premiums over the undisturbed price. It's essentially a premium paid in a currency (stock) that’s fallen 22%. Welcome any pushback on my napkin math calcs. By no means a comprehensive model.

Investor Letters

All letters

Entravision Q3 Update

Entravision’s Q3 ad-tech revenue reached $177.2 million, up 133% year over year, while total revenue rose 88% to $226.3 million and diluted…

EVC $832M
The Value Road 4 clicks

Axon 3Q26 Business Update

Axon cut full-year guidance after delayed federal Dedrone contracts slowed 3Q revenue growth to 28%, while software and services grew 43%.

AXON $31B
Speedwell Memos 2 clicks

GREAT DEC-TECTIVE WORK

Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…

DEC $900M
The Oak Bloke 2 clicks

ARM Q2 FY3/27 Earnings Review

Arm reported Q2 revenue of $1.443 billion, up 27%, as licensing rose 50% while royalties grew 8%; Q3 guidance calls for $1.54 billion.

ARM $181B
Cestrian Capital Research

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.